Clinical Trial Update: Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated the safety and potential efficacy of cannabidiol as a treatment intervention for opioid relapse. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Hurd,Yasmin, Ph.D. | Conditions: Opiate Addiction | Phase 1 | Status: COMPLETED